This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gaur, A. Articles by Israel, M. A. Search for Related Content PubMed PubMed Citation Articles by Gaur, A. Articles by Israel, M. A.

Characterization of MicroRNA Expression Levels and Their Biological Correlates in Human Cancer Cell Lines

¹ Norris Cotton Cancer Center and ² Department of Genetics, Dartmouth Medical School, Lebanon, New Hampshire; and ³ Molecular Cell Biology-R&D, Applied Biosystems, Foster City, California

Requests for reprints: Mark A. Israel, Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, NH 03755. Phone: 603-653-3611; Fax: 603-653-9003; E-mail: Mark.A.Israel{at}dartmouth.edu.

MicroRNAs are small noncoding RNAs that function by regulating target gene expression posttranscriptionally. They play a critical role in developmental and physiologic processes and are implicated in the pathogenesis of several human diseases including cancer. We examined the expression profiles of 241 human microRNAs in normal tissues and the NCI-60 panel of human tumor-derived cell lines. To quantify microRNA expression, we employed a highly sensitive technique that uses stem-loop primers for reverse transcription followed by real-time PCR. Most microRNAs were expressed at lower levels in tumor-derived cell lines compared with the corresponding normal tissue. Agglomerative hierarchical clustering analysis of microRNA expression revealed four groups among the NCI-60 cell lines consisting of hematologic, colon, central nervous system, and melanoma tumor–derived cell lines clustered in a manner that reflected their tissue of origin. We identified specific subsets of microRNAs that provide candidate molecular signatures characteristic of the tumor-derived cell lines belonging to these four clusters. We also identified specific microRNA expression patterns that correlated with the proliferation indices of the NCI-60 cell lines, and we developed evidence for the identification of specific microRNAs as candidate oncogenes and tumor suppressor genes in different tumor types. Our results provide evidence that microRNA expression patterns may mark specific biological characteristics of tumors and/or mediate biological activities important for the pathobiology of malignant tumors. These findings call attention to the potential of microRNAs to provide etiologic insights as well as to serve as both diagnostic markers and therapeutic targets for many different tumor types. [Cancer Res 2007;67(6):2456–68]

This article has been cited by other articles:

				P. Wang, F. Zou, X. Zhang, H. Li, A. Dulak, R. J. Tomko Jr., J. S. Lazo, Z. Wang, L. Zhang, and J. Yu microRNA-21 Negatively Regulates Cdc25A and Cell Cycle Progression in Colon Cancer Cells Cancer Res., October 15, 2009; 69(20): 8157 - 8165. [Abstract] [Full Text] [PDF]

				Y. Li, F. Guessous, Y. Zhang, C. DiPierro, B. Kefas, E. Johnson, L. Marcinkiewicz, J. Jiang, Y. Yang, T. D. Schmittgen, et al. MicroRNA-34a Inhibits Glioblastoma Growth by Targeting Multiple Oncogenes Cancer Res., October 1, 2009; 69(19): 7569 - 7576. [Abstract] [Full Text] [PDF]

				S. Sakamoto, K. Aoki, T. Higuchi, H. Todaka, K. Morisawa, N. Tamaki, E. Hatano, A. Fukushima, T. Taniguchi, and Y. Agata The NF90-NF45 Complex Functions as a Negative Regulator in the MicroRNA Processing Pathway Mol. Cell. Biol., July 1, 2009; 29(13): 3754 - 3769. [Abstract] [Full Text] [PDF]

				D. P. Pandey and D. Picard miR-22 Inhibits Estrogen Signaling by Directly Targeting the Estrogen Receptor {alpha} mRNA Mol. Cell. Biol., July 1, 2009; 29(13): 3783 - 3790. [Abstract] [Full Text] [PDF]

				R. Ueda, G. Kohanbash, K. Sasaki, M. Fujita, X. Zhu, E. R. Kastenhuber, H. A. McDonald, D. M. Potter, R. L. Hamilton, M. T. Lotze, et al. Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1 PNAS, June 30, 2009; 106(26): 10746 - 10751. [Abstract] [Full Text] [PDF]

				N. S. Wickramasinghe, T. T. Manavalan, S. M. Dougherty, K. A. Riggs, Y. Li, and C. M. Klinge Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells Nucleic Acids Res., May 1, 2009; 37(8): 2584 - 2595. [Abstract] [Full Text] [PDF]

				H.-W. Hwang, E. A. Wentzel, and J. T. Mendell Cell-cell contact globally activates microRNA biogenesis PNAS, April 28, 2009; 106(17): 7016 - 7021. [Abstract] [Full Text] [PDF]

				T.-C. Chang, L. R. Zeitels, H.-W. Hwang, R. R. Chivukula, E. A. Wentzel, M. Dews, J. Jung, P. Gao, C. V. Dang, M. A. Beer, et al. Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation PNAS, March 3, 2009; 106(9): 3384 - 3389. [Abstract] [Full Text] [PDF]

				R. J. Webster, K. M. Giles, K. J. Price, P. M. Zhang, J. S. Mattick, and P. J. Leedman Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7 J. Biol. Chem., February 27, 2009; 284(9): 5731 - 5741. [Abstract] [Full Text] [PDF]

				Y. Horikawa, C. G. Wood, H. Yang, H. Zhao, Y. Ye, J. Gu, J. Lin, T. Habuchi, and X. Wu Single Nucleotide Polymorphisms of microRNA Machinery Genes Modify the Risk of Renal Cell Carcinoma Clin. Cancer Res., December 1, 2008; 14(23): 7956 - 7962. [Abstract] [Full Text] [PDF]

				S. Asada, T. Takahashi, K. Isodono, A. Adachi, H. Imoto, T. Ogata, T. Ueyama, H. Matsubara, and H. Oh Downregulation of Dicer expression by serum withdrawal sensitizes human endothelial cells to apoptosis Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2512 - H2521. [Abstract] [Full Text] [PDF]

				B. Kefas, J. Godlewski, L. Comeau, Y. Li, R. Abounader, M. Hawkinson, J. Lee, H. Fine, E. A. Chiocca, S. Lawler, et al. microRNA-7 Inhibits the Epidermal Growth Factor Receptor and the Akt Pathway and Is Down-regulated in Glioblastoma Cancer Res., May 15, 2008; 68(10): 3566 - 3572. [Abstract] [Full Text] [PDF]

				K. A. Cole, E. F. Attiyeh, Y. P. Mosse, M. J. Laquaglia, S. J. Diskin, G. M. Brodeur, and J. M. Maris A Functional Screen Identifies miR-34a as a Candidate Neuroblastoma Tumor Suppressor Gene Mol. Cancer Res., May 1, 2008; 6(5): 735 - 742. [Abstract] [Full Text] [PDF]

				M. N. Nikiforova, G. C. Tseng, D. Steward, D. Diorio, and Y. E. Nikiforov MicroRNA Expression Profiling of Thyroid Tumors: Biological Significance and Diagnostic Utility J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1600 - 1608. [Abstract] [Full Text] [PDF]

				K.-i. Kozaki, I. Imoto, S. Mogi, K. Omura, and J. Inazawa Exploration of Tumor-Suppressive MicroRNAs Silenced by DNA Hypermethylation in Oral Cancer Cancer Res., April 1, 2008; 68(7): 2094 - 2105. [Abstract] [Full Text] [PDF]

				S.-M. Park, A. B. Gaur, E. Lengyel, and M. E. Peter The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 Genes & Dev., April 1, 2008; 22(7): 894 - 907. [Abstract] [Full Text] [PDF]

				W.-X. Wang, B. W. Rajeev, A. J. Stromberg, N. Ren, G. Tang, Q. Huang, I. Rigoutsos, and P. T. Nelson The Expression of MicroRNA miR-107 Decreases Early in Alzheimer's Disease and May Accelerate Disease Progression through Regulation of {beta}-Site Amyloid Precursor Protein-Cleaving Enzyme 1 J. Neurosci., January 30, 2008; 28(5): 1213 - 1223. [Abstract] [Full Text] [PDF]

				H. Yang, W. Kong, L. He, J.-J. Zhao, J. D. O'Donnell, J. Wang, R. M. Wenham, D. Coppola, P. A. Kruk, S. V. Nicosia, et al. MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN Cancer Res., January 15, 2008; 68(2): 425 - 433. [Abstract] [Full Text] [PDF]

				I. D. Moffat, P. C. Boutros, T. Celius, J. Linden, R. Pohjanvirta, and A. B. Okey microRNAs in Adult Rodent Liver Are Refractory to Dioxin Treatment Toxicol. Sci., October 1, 2007; 99(2): 470 - 487. [Abstract] [Full Text] [PDF]

				S. Shell, S.-M. Park, A. R. Radjabi, R. Schickel, E. O. Kistner, D. A. Jewell, C. Feig, E. Lengyel, and M. E. Peter Let-7 expression defines two differentiation stages of cancer PNAS, July 3, 2007; 104(27): 11400 - 11405. [Abstract] [Full Text] [PDF]

				P. E. Blower, J. S. Verducci, S. Lin, J. Zhou, J.-H. Chung, Z. Dai, C.-G. Liu, W. Reinhold, P. L. Lorenzi, E. P. Kaldjian, et al. MicroRNA expression profiles for the NCI-60 cancer cell panel Mol. Cancer Ther., May 1, 2007; 6(5): 1483 - 1491. [Abstract] [Full Text] [PDF]